Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EEF1E1-BLOC1S5 readthrough (EEF1E1-BLOC1S5)
- Target
- EEF1E1-BLOC1S5
- Molecular classification
- lncRNA (long noncoding RNA), RNA gene
01
Overview
EEF1E1-BLOC1S5 readthrough (NMD candidate) is generated by natural read-through transcription between the adjacent EEF1E1 and BLOC1S5 genes on chromosome 6. The resulting transcript is classified as a long noncoding RNA and is considered a candidate for nonsense-mediated mRNA decay, meaning it is unlikely to produce a functional protein product. There is no evidence in current genomic resources for its direct involvement as a therapeutic target, nor for protein expression or drug interactions. The gene has been linked to Hermansky-Pudlak Syndrome types 1 and 11, but its clinical or biological significance is unclear and is likely secondary to overlapping gene regions or misannotation.
- Other names
- EEF1E1-BLOC1S5EEF1E1-BLOC1S5 readthroughHGNC: 49187NCBI Gene: 100526837Ensembl: ENSG00000265818UniProtKB/TrEMBL: C9J1V9
02
Biological functions
Other: Candidate for nonsense-mediated mRNA decay; no reported protein-coding or functional role
03
Disease associations
Hermansky-Pudlak Syndrome 11Hermansky-Pudlak Syndrome 1
Beyond the preview
Go deeper on EEF1E1-BLOC1S5 readthrough (EEF1E1-BLOC1S5).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EEF1E1-BLOC1S5 readthrough (EEF1E1-BLOC1S5).